Andes Raises Usd 15 Million In Series A Funding Co-Led By Leaps By Bayer And Cavallo Ventures

Sep 14, 2021•almost 4 years ago

Amount Raised

$15 Million

Round Type

series a

Leverkusen

Description

Leaps by Bayer, the impact investment arm of Bayer AG, today announced that it has co-led a USD 15 million Series A investment round in agriculture and biotechnology innovator, Andes, with Cavallo Ventures. Other new investors Builders VC, Germin8, Accelr8 and Wilson Sonsini participated, alongside existing investors KdT Ventures and Endurance.

Company Information

Company

Andes

Location

Leverkusen, North Rhine-Westphalia, Germany

About

Andes is a biotechnology company founded in Emeryville, CA, in 2018. Andes develops biological solutions that enable positive action for fighting climate change. Andes empowers microbes by engineering them and has developed a process for seamlessly integrating microbes into the agriculture process. Andes first generation of solutions focus on the agricultural industry. Through its novel microbial seed treatment technology called Microprime, Andes is reducing the need for synthetic fertilizers by enabling the seed to draw down nitrogen from the air. Andes is also developing microbes that thrive in plant roots and can create nature-based permanent carbon capture solutions to sequester and store CO2 from the atmosphere into the soil. Both solutions have the potential to reduce annual CO2 emissions by the gigaton. For more information go to www.andes.bio. Find more information at www.bayer.com.

Funding Insights

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech